Jane Street
RCKT icon

Jane Street’s Rocket Pharmaceuticals RCKT Stock Holding History

Jane Street’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78K Buy
+21,800
New +$86.6K ﹤0.01% 10759
2025
Q4 		– Sell
-68,900
Closed -$225K – 12146
2025
Q3 		$225K Sell
68,900
-1,600
-2% -$5.04K ﹤0.01% 9449
2025
Q2 		$173K Buy
70,500
+56,400
+400% +$286K ﹤0.01% 8653
2025
Q1 		$94K Buy
+14,100
New +$139K ﹤0.01% 8831
2024
Q4 		– Sell
-10,900
Closed -$201K – 10358
2024
Q3 		$201K Sell
10,900
-88,400
-89% -$1.81M ﹤0.01% 8637
2024
Q2 		$2.14M Buy
99,300
+41,200
+71% +$946K ﹤0.01% 4362
2024
Q1 		$1.57M Sell
58,100
-342,900
-86% -$9.74M ﹤0.01% 4576
2023
Q4 		$12M Buy
401,000
+16,800
+4% +$371K ﹤0.01% 1755
2023
Q3 		$7.87M Buy
384,200
+300,900
+361% +$5.47M ﹤0.01% 2057
2023
Q2 		$1.66M Buy
83,300
+1,000
+1% +$20.2K ﹤0.01% 4450
2023
Q1 		$1.41M Buy
82,300
+67,200
+445% +$1.32M ﹤0.01% 4403
2022
Q4 		$296K Sell
15,100
-13,900
-48% -$256K ﹤0.01% 7046
2022
Q3 		$463K Buy
29,000
+14,800
+104% +$231K ﹤0.01% 6830
2022
Q2 		$195K Buy
+14,200
New +$169K ﹤0.01% 8212
2021
Q4 		– Sell
-26,900
Closed -$804K – 10689
2021
Q3 		$804K Sell
26,900
-11,500
-30% -$419K ﹤0.01% 6355
2021
Q2 		$1.7M Buy
+38,400
New +$1.67M ﹤0.01% 4666

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Jane Street's RCKT Position: Q1 2026 in Review

Jane Street increased its Rocket Pharmaceuticals (RCKT) stake by 3.4% in Q1 2026, buying an estimated $82.6K and bringing the position to 623,354 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4873.

Jane Street first reported a position in RCKT in Q3 2020 and has held it in 21 quarters since. The position peaked at $3.28M in Q3 2024. 198 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.

  • Jane Street held 623,354 shares of Rocket Pharmaceuticals worth $2.23M as of Q1 2026.
  • Jane Street bought 20,774 Rocket Pharmaceuticals shares in Q1 2026, an estimated $82.6K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4873 holding.
  • Jane Street first reported a position in Rocket Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • Jane Street's Rocket Pharmaceuticals position peaked at $3.28M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.